ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,341, issued on April 21, was assigned to VICORE PHARMA AB (Stockholm).
"Dry powder composition for peroral administration" was invented by Ola Camber (Stockholm), Arnout Everaert (Mariakerke, Belgium) and Stefan Gruden (Uppsala, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided a pharmaceutical dosage form that is suitable for peroral administration to the gastrointestinal tract, which dosage form comprises a pharmaceutical composition in the form of a particulate mixture comprising solid particles of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (C21), or a pharmaceutically-acceptable s...